400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / HSV / B220
CAS No.: 112228-65-6
B220 is an antiviral agent which can inhibit the growth of HSV-1, HSV-2 and human cytomegalovirus (CMV).
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00915343 | Adrenal Insufficiency | Phase 2 Phase 3 | Completed | - | - |
NCT00690638 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01174225 | Contraception | Phase 4 | Active, not recruiting | December 2020 | Canada, British Columbia ... more >> Kelowna Womens' Clinic Kelowna, British Columbia, Canada Collapse << |
实验方案
技术信息
CAS号 | 112228-65-6 | 储存条件 |
|
|
分子式 | C20H22N4 | 运输 | 蓝冰 | |
分子量 | 318.42 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00915343 | Adrenal Insufficiency | Phase 2 Phase 3 | Completed | - | - |
NCT00690638 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01174225 | Contraception | Phase 4 | Active, not recruiting | December 2020 | Canada, British Columbia ... more >> Kelowna Womens' Clinic Kelowna, British Columbia, Canada Collapse << |
NCT02509247 | Sleep Apnea | Not Applicable | Completed | - | Finland ... more >> Turku University Hospital Turku, Finland, 20521 Collapse << |
NCT00363012 | Breast Cancer | Not Applicable | Completed | - | United States, Washington ... more >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109-1024 Tumor Vaccine Group at the University of Washington Seattle, Washington, United States, 98109 Collapse << |
NCT00915343 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网